Utility Navigation About Locations Contact Menu Home Therapeutic Areas Infectious Diseases Share this Infectious Diseases Rely on PPD’s experienced infectious diseases team to deliver the optimal clinical strategy. As new markets are identified for conducting clinical research, our team is already on the ground and well-prepared to start trials quickly and keep them on track. PPD has conducted more than 700 government and commercial trials in infectious diseases indications involving more than 13,500 sites and 320,000 patients over the past five years. PPD’s experienced infectious diseases team: Offers reliable access to patients worldwide Applies deep therapeutic experience and global resources to streamline the development process from clinical through post-approval Uses our global network of monitors, project managers, regulatory specialists, data managers, biostatisticians, medical writers, lab technicians, scientists and medical professionals to ensure rapid, efficient execution of clinical trials Infectious Diseases Global Investigator Network PPD’s robust global investigator database includes more than 1,600 adult and pediatric infectious diseases specialists in 59 countries in various specialties, including HIV, hepatitis C, parasitic diseases and medical microbiology. With experience in a broad range of infectious diseases indications, these investigators provide access to specialized clinical sites with proven trial experience. Microbiology Laboratory Services PPD's central laboratories support clinical trials worldwide in infectious diseases drug development through our laboratory testing services and expanded capabilities in our clinical microbiology laboratories. PPD offers clients: A full range of microbiology testing services, such as bacteriology, mycobacteriology and testing of microbioterrorism pathogens Extensive virology testing, including real-time polymerase chain reaction, viral load, genotyping and single nucleotide polymorphism analysis The capability to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms A flexible approach to microbiology testing, performing disk diffusion and/or broth dilution assays to establish antibiotic minimum inhibitory concentration and breakpoints Considerations for the Design and Conduct of Clinical Trials for Hepatitis C Explore the nuances of the hepatitis C virus (HCV) that continue to impact the treatment strategies for the disease. Read More Influenza A Strains Highlight Vaccine Needs In the past six years, the public’s awareness of morbidity and mortality caused by influenza A has increased significantly, mainly due to two of the disease’s notable strains. Read More Related Content Study Experience Regulatory Requirements for Clinical Development of Novel Influenza Vaccines Savanna Steele, Pharm.D. Cardiovascular Critical Care Dermatology Dental Pain Research Endocrine and Metabolics Gastroenterology Hematology & Oncology Immunology Infectious Diseases Study Experience Antivirals Vaccine Development Neuroscience Ophthalmology Respiratory Urology Contact Us Connect With Us We want to hear from you Investigators Needed Register in PPD's Database Stay Connected RSS Twitter LinkedIn Facebook SERVICES Contact Services Discovery Early Development Clinical Development PPD® Laboratories Post-Approval PPD® Consulting Technology, Innovation & Performance Industry Expertise Events THERAPEUTIC AREAS Cardiovascular Critical Care Dermatology Dental Pain Research Endocrine and Metabolics Gastroenterology Hematology & Oncology Immunology Infectious Diseases Neuroscience Ophthalmology Respiratory Urology PARTICIPATE IN A TRIAL Volunteer for a Study Become an Investigator EXPERT COMMUNITY Clinical Trials Emerging Markets Labs Services Therapeutic Areas NEWS & EVENTS PPD In The News News Events Media Kit ABOUT CAREERS SITE MAP Contact Site Map Legal Notices Privacy Policy © 2015 Pharmaceutical Product Development, LLC. All rights reserved. Google+